Aprea Therapeutics, Inc. · NASDAQ:APRE
LYTTON LAURENCE W reported a 9.90% stake in Aprea Therapeutics, Inc. (Schedule 13G)
Event Nov 13, 2025 · Filed Nov 17, 2025
LYTTON LAURENCE W reported a 9.90% stake in Aprea Therapeutics, Inc., 681,837 shares, as a passive investor on Nov 13, 2025. Filed Nov 17, 2025 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 681,837
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| LYTTON LAURENCE W | 9.90% | 681,837 |
Source
Related
- Aprea Therapeutics, Inc.
- Laurence W. Lytton
- Aprea Therapeutics, Inc. shareholders
- Schedule 13G/A · Laurence W. Lytton · Aug 13, 2026
- Form 4 · Grissinger Michael · Jun 17, 2026
- Form 4 · Gruia Gabriela · Jun 17, 2026
- Form 4 · Peters Richard · Jun 17, 2026
- Form 4 · Henneman John B III · Jun 17, 2026
- Form 4 · Bizzari Jean-Pierre · Jun 17, 2026